Dimensional Fund Advisors LP cut its position in National Health Investors, Inc. (NYSE:NHI – Get Rating) by 1.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 607,857 shares of the real estate investment trust’s stock after selling 7,205 shares during the quarter. Dimensional Fund Advisors LP owned about 1.40% of National Health Investors worth $31,741,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in NHI. State Street Corp increased its stake in shares of National Health Investors by 15.9% during the 1st quarter. State Street Corp now owns 2,186,194 shares of the real estate investment trust’s stock worth $130,904,000 after purchasing an additional 299,737 shares during the last quarter. Millennium Management LLC boosted its stake in shares of National Health Investors by 7,218.8% during the 2nd quarter. Millennium Management LLC now owns 258,574 shares of the real estate investment trust’s stock worth $15,672,000 after acquiring an additional 255,041 shares during the period. UBS Oconnor LLC increased its holdings in shares of National Health Investors by 177.8% during the 3rd quarter. UBS Oconnor LLC now owns 124,319 shares of the real estate investment trust’s stock worth $7,028,000 after acquiring an additional 79,574 shares during the last quarter. Renaissance Technologies LLC acquired a new position in shares of National Health Investors during the 1st quarter worth approximately $4,131,000. Finally, Vanguard Group Inc. lifted its holdings in National Health Investors by 1.0% during the 1st quarter. Vanguard Group Inc. now owns 6,404,110 shares of the real estate investment trust’s stock valued at $377,907,000 after purchasing an additional 60,990 shares during the last quarter. 62.44% of the stock is owned by institutional investors.
Analyst Ratings Changes
NHI has been the topic of several research analyst reports. StockNews.com started coverage on shares of National Health Investors in a research report on Thursday, May 18th. They issued a “hold” rating on the stock. Credit Suisse Group reduced their price target on National Health Investors from $55.00 to $50.00 and set a “neutral” rating for the company in a research note on Wednesday, March 29th. Finally, Wells Fargo & Company initiated coverage on National Health Investors in a report on Wednesday, April 19th. They set an “equal weight” rating and a $52.00 target price for the company. Five analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to MarketBeat, National Health Investors presently has an average rating of “Hold” and a consensus price target of $57.80.
National Health Investors Stock Performance
NYSE NHI opened at $52.37 on Friday. The firm’s 50 day simple moving average is $50.74 and its 200 day simple moving average is $53.50. The firm has a market capitalization of $2.27 billion, a price-to-earnings ratio of 25.18 and a beta of 0.91. The company has a current ratio of 12.71, a quick ratio of 12.71 and a debt-to-equity ratio of 0.92. National Health Investors, Inc. has a 1 year low of $47.54 and a 1 year high of $67.16.
National Health Investors Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 4th. Investors of record on Friday, June 30th will be given a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a yield of 6.87%. The ex-dividend date is Thursday, June 29th. National Health Investors’s dividend payout ratio is 173.08%.
National Health Investors Company Profile
National Health Investors, Inc engages in the sale-leaseback, joint-venture, mortgage, and mezzanine financing of senior housing and medical investments. It operates through the Real Estate Investments and Senior Housing Operating Portfolio (SHOP) segments. The Real Estate Investments segment includes real estate investments and lease, mortgage, and other notes receivables in independent living facilities.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider National Health Investors, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and National Health Investors wasn’t on the list.
While National Health Investors currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
Source: marketbeat.com
